How to Be Efficient and Effective. Disclosure. Topics CASE CM. Case JF 2007 OHTN / POAG? How to Be Efficient and Effective with. with New Technology

Similar documents
Mark Dunbar: Disclosure

Advances in OCT Murray Fingeret, OD

Optical Coherence Tomography (OCT)

Evolving glaucoma management True diagnostic integration for the preservation of vision

Ganglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD

Structural examina.on: Imaging

STRUCTURE & FUNCTION An Integrated Approach for the Detection and Follow-up of Glaucoma. Module 3a GDx

Cirrus TM HD-OCT. Details defi ne your decisions

OCT in the Diagnosis and Follow-up of Glaucoma

Glaucoma Pearls and Grand Rounds Vision Expo East 2016

Is this glaucoma? Leo Semes, OD Michael Chaglasian, OD Danica Marrelli, OD. Optometry s Meeting 2015 Seattle, WA

Financial Disclosure. Maximizing OCT in Diagnosis and Management of Glaucoma. Case 1: Dennis, 65yo WM DIAGNOSIS: CASES 1 2 7/29/2016

Noel de Jesus Atienza, MD, MSc and Joseph Anthony Tumbocon, MD

8/6/17. Disclosures Aerie Pharmaceuticals Alcon BioTissue Diopsys Optovue Shire

Il contributo dell'angio-oct: valutazione integrata della componente nervosa e vascolare della malattia glaucomatosa

Automated Visual Field Analysis for Glaucoma

Cirrus TM HD-OCT. Details define your decisions

PRIMUS 200 from ZEISS The essential OCT

Glaucoma Diagnosis & Tracking with Optical Coherence Tomography

PRIMUS 200 from ZEISS The essential OCT

Do You See What I See!!! Shane R. Kannarr, OD

Structure WGA. Structure WGA. Structural Assessment in Glaucoma. What s New

Glaucoma Evaluation. OCT Pearls for Glaucoma. OCT: Retinal Nerve Fiber Layer. Financial Disclosures. OCT: Macula. Case Example

Ganglion cell complex scan in the early prediction of glaucoma

Moving forward with a different perspective

Structural & Functional Optical Coherence Tomography for Glaucoma Diagnosis

Macular Ganglion Cell Complex Measurement Using Spectral Domain Optical Coherence Tomography in Glaucoma

tracking progression we can better manage our patients. Like any tool, any instrument you ve got to

Glaucoma Progression. Murray Fingeret, OD

Method for comparing visual field defects to local RNFL and RGC damage seen on frequency domain OCT in patients with glaucoma.

Intro to Glaucoma/2006

History/principles of the OCT What does the normal retinal OCT look like Vitreal disorders Retinal/RPE disorders Choroidal disorders

Translating data and measurements from stratus to cirrus OCT in glaucoma patients and healthy subjects

DISCLOSURE: What to do? 2/22/2016

The World s fastest OCT. As simple as pressing. the start button

Glaucoma Diagnosis. Definition of Glaucoma. Diagnosing Glaucoma. Vision Institute Annual Fall Conference

1/25/2019 OCT & OCTA RETINAL IMAGING: HOW TO PREVENT RAGING GLAUCOMA! THE ORIGINAL RAGING GLAUCOMA OCT RETINAL IMAGING OPTIC NERVE HEAD EXAMINATION

Course # Getting to Know Your OCT

Comparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements

The Measure of Confidence

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.

RETINA REVEALED. Dynamic Developments in AMD Diagnosis and Treatment (2014) The Dawn of: Pharmaco-Genetics (aka Nutrigenomics) Jerome Sherman, OD

University Hospital Basel. Optical Coherence Tomography Emerging Role in the Assessment of MS PD Dr. Konstantin Gugleta

OtticaFisiopatologica

New Technologies in Glaucoma Management: From ERG to OCT

C a t a r a c t G l a u c o m a R e t i n a R e f r a c t i v e. The GDxVCC Early answers and ongoing assessment for glaucoma

53 year old woman attends your practice for routine exam. She has no past medical history or family history of note.

Local Coverage Determination (LCD): Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) (L34431)

Goals. Glaucoma PARA PEARL TO DO. Vision Loss with Glaucoma

International Journal of Scientific & Engineering Research, Volume 4, Issue 12, December ISSN

Visualize. Analyze. Personalize. OCT + OCTA

Gonioscopy and Slit Lamp Exam for the Glaucoma Suspect. Disclosure GONIOSCOPY: Gonioscopy Why?? What should I look for? GONIOSCOPY

Incorporating OCT Angiography Into Patient Care

SOUTH-EAST EUROPEAN JOURNAL of OPHTHALMOLOGY 2015; 1 (1) 34 40

OCT Interpretation in Retinal Disease

The Role of the RNFL in the Diagnosis of Glaucoma

HOW TO MAKE THE MOST OF A NEW OCT. with Kelly Kerksick, OD

Dr. Harvey Richman, OD, FAAO, FCOVD Diplomate American Board of Optometry Executive Committee AOA Third Party Center Founder Ask the AOA Coding

To assess the glaucoma diagnostic ability of Fourier Domain Optical Coherence Tomography

Available online at Pelagia Research Library. Advances in Applied Science Research, 2013, 4(6):

OCT Image Analysis System for Grading and Diagnosis of Retinal Diseases and its Integration in i-hospital

Visual Field Interpretation Anthony B. Litwak, OD, FAAO VA Medical Center Baltimore, MD

Introducing ANGIOVUE ESSENTIAL. Built on the Avanti Widefield OCT Platform. OCT Angiography for Primary Eye Care

Jong Chul Han, Da Ye Choi, and Changwon Kee. 1. Introduction

Retinal nerve fiber layer thickness in Indian eyes with optical coherence tomography

Title: OCT Analysis Workshop: Interpretation of OCT printouts

A Formula to Predict Spectral Domain Optical Coherence Tomography (OCT) Retinal Nerve Fiber Layer Measurements Based on Time Domain OCT Measurements

Early Detection Of Glaucoma Clinical Clues. Points To Live By. Glaucoma Risk Factors 10/3/2014

CHAPTER 13 CLINICAL CASES INTRODUCTION

A Review Of Risk Factors. Early Detection Of Glaucoma Clinical Clues. A risk factor analysis is critical. Points To Live By

Retinal Nerve Fiber Layer Measurements in Myopia Using Optical Coherence Tomography

New Concepts in Glaucoma Ben Gaddie, OD Moderator Murray Fingeret, OD Louis Pasquale, MD

Linking structure and function in glaucoma

Optical coherence tomography (OCT) is a relatively new noninvasive. The Use of Optical Coherence Tomography in Neurology DIAGNOSTIC UPDATE

SOCT Copernicus REVO. * - Currently import and overlay are avaibale in manual mode only

Research Article The Pattern of Retinal Nerve Fiber Layer and Macular Ganglion Cell-Inner Plexiform Layer Thickness Changes in Glaucoma

Glaucoma: a disease of the macula?

OCT & Optic nerve. Pr. Jean-Philippe Nordmann Glaucoma Centre - Hôpital des Quinze-Vingts, Paris

Financial Disclosure. Visual Field Interpretation RELIABILITY VISUAL FIELD INTERPRETATION IN GLAUCOMA METHODS OF DATA PRESENTATION

Electrodiagnostics Alphabet Soup

Non-arteritic anterior ischemic optic neuropathy (NAION) with segmental optic disc edema. Jonathan A. Micieli, MD Valérie Biousse, MD

Snellen VA 2 IOP 3 Ocular Examination * Only dilate if repeat photos required

Visualize. Analyze. Personalize. OCT + OCTA. with

04/11/2014. Retina Coding and Reimbursement 101. Financial Disclosure. Chief Complaint

DRI OCT Triton Series A Multimodal Swept Source OCT

Research Article Repeatability of Perimacular Ganglion Cell Complex Analysis with Spectral-Domain Optical Coherence Tomography

Corporate Medical Policy

Glaucoma Clinical Update. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012

HOCT-1I 1F All-in-One Optical Coherence Tomography with Fundus

What Is O.C.T. and Why Should I Give A Rip? OCT & Me How Optical Coherence Tomography Changed the Life of a Small Town Optometrist 5/19/2014

WORKSHOP B Ophthalmic Imaging: All Hands on Tech! COPE Course PS

Corporate Medical Policy

Although glaucoma is classified as an optic nerve disease,

Seiji T. Takagi, Yoshiyuki Kita, Asuka Takeyama, and Goji Tomita. 1. Introduction. 2. Subjects and Methods

Evaluation of ONH Pallor in Glaucoma Patients and Suspects. Leticia Rousso, O.D. Joseph Sowka, O.D

Fundus Autofluorescence. Jonathan A. Micieli, MD Valérie Biousse, MD

Glaucoma: Diagnostic Modalities

7/25/2018. You talk about glaucoma in cup-to-disc ratios ASSESSING THE OPTIC DISC: IS PHOTOGRAPHY STILL NECESSARY IN THE OCT ERA?

21st Century Visual Field Testing

CLINICAL SCIENCES. Felipe A. Medeiros, MD; Linda M. Zangwill, PhD; Christopher Bowd, PhD; Robert N. Weinreb, MD

Transcription:

How to Be Efficient and Effective with Disclosure COPE Course ID: 40750 GL Michael Chaglasian has the following disclosures: 1. Advisory Board: Allergan, Inc., Alcon Labs, B+L Carl Zeiss Meditec 2. Research: Topcon Michael Chaglasian, OD Illinois Eye Institute Illinois College of Optometry mchaglas@ico.edu The content of this presentation is in no manner influenced by any of the aforementioned parties or companies Topics Imaging Instrumentation OCTs Photos Perimetry Printouts Progression Analysis PACS for Viewing this stuff picture archiving and communication system Image Management System CASE CM 38 yo GAT= 22 OD 25 OS 3 Case JF 2007 OHTN / POAG? IMAGING AND OPTOMETRY 16 Michael Chaglasian, OD 1

Possible Indications for Performing OCT Requirements of OCT Technology Elevated IOP > 21mm Hg C/D >.5 or Asymm. > 0.2 Poor visual field test-takers Narrow anterior chamber angles High myopia Personal or family history of -diabetes -glaucoma -hypertension - field defects Suspicious Optic Nerves - Marcus Gunn pupil - Acquired color defect - poor confrontation fields - Disc pallor Unexplained decreased vision Drusen / AMD Numerous maculopathies and retinopathies And Many Others Validation / Accuracy / Improved Outcomes Peer reviewed articles in the literature Not sales/marketing hype Cost Effectiveness Can be challenging. Survey your patients for three months Consider added value to your practice Ease of Use / Ease of Interpretation OCT out performs Photography Growth of OCT (2009) Conclusions: For detection of a variety of retinal irregularities evaluated in the current study, volume OCT scanning was more sensitive than non-mydriatic retinal photography in our asymptomatic individuals. OCT detected clinically relevant disease features, such as subretinal fluid, that were missed by FP, and had a lower ungradable image rate. It is likely that OCT will be added to photography screening in the near future for chorioretinal disease. The Retinal Disease Screening Study: Prospective Comparison of Nonmydriatic Fundus Photography and Optical Coherence Tomography for Detection of Retinal Irregularities IOVS February 2013 54:1460-1468;published ahead of print January 15, 2013. OCT Coding / Billing 2014 92132- Used for cornea and narrow angle diagnoses Some carriers/insurances are not covering 92133- Used for ALL Glaucoma and optic neuropathy diagnoses 92134- Used for ALL (approved) Retinal diagnoses Mutually exclusive and cannot be billed on the same day as 92133. Can be billed with 92132. None can billed on same day as fundus photos, 92250 OCT Coding / Billing 2014 Must be based upon Medical Necessity and entering CC / reason for visit Reason for diagnostic test? Directly stated or easily implied Will it effect diagnosis or treatment? Always requires an Order and an Interpretation and Report Michael Chaglasian, OD 2

2014 Avg. Reimbursement: John Rumpakis, OD, MBA $45-48 Each of these new codes is considered unilateral or bilateral Frequency varies with diagnosis Obtain List of covered ICD-9 codes (Medicare LCD) Here s the bottom line: Your patients medical insurance is not the same thing as your malpractice insurance. http://www.revoptom.com/content/d/coding and practice_management/c/36039/ Optimize Revenue The OCT model can help you improve your billing and coding Help you build glaucoma and retina patients According to Dr. John Rumpakis, a new glaucoma patient can require procedures valued up to $985 the first year. 1 FIRST YEAR GLAUCOMA PATIENT REVENUE VISIT # TOTAL FEES PER VISIT RUNNING TOTAL FIRST $164 $164 SECOND $288 $452 THIRD $224 $676 FOURTH $ 55 $731 FIFTH $144 $875 SIXTH $ 55 $930 SEVENTH $ 55 $985 ADDITIONAL INCOME DUE TO IMPROVED CASE DETECTION One ROI Example: OCT only 13.5 per month or 3.4 week for breakeven Procedures for each Glaucoma suspect and diagnosed, 2nd and 3rd visits 2 92014 Ophthalmological services, comprehensive medical examination $ 113 92250 Fundus Photography $ 47 92020 Gonioscopy $ 26 92083 Threshold Visual Fields $ 52 76514 Corneal Pachymetry $ 12 92012 Ophthalmological services, intermediate $ 77 92132 Dqiagnostic Anterior Digital Imaging, - Spectralis $ 38 92133 Diagnostic Posterior ONH Digital Imaging, -Spectralis $ 42 Income generated by two follow-up visits of each glaucoma suspect $ 407 2. Rumpakis, Putting an Economic Spin on Glaucoma, Optometric Management March 2004, pp 53-54. 1 Rumpakis, Putting an Economic Spin on Glaucoma, Optometric Management, Marc There is no guarantee that your Medicare carrier will pay for these procedures when performed on the same day. Please contact your local Medicare carrier to determine appropriate billing guidelines. It s definitely not getting easier. Spectral http://www.revoptom.com/content/c/22520/ Michael Chaglasian, OD 3

OCT Time Domain Stratus Strengths Provides Cross Sectional images Useful to calculate RNFL thickness Cross section scans useful for retinal pathologies Database comparisons Weaknesses Slow scan speed (400 A scans / second) Limited data for glaucoma, 768 pixel (A-scan) ring for RNFL Limited data for retina, 6 radial lines with 128 A scans (pixels) each Macula maps 97% interpolated No progression analysis Location of scan ring affects RNFL results Prone to motion artifacts because of slow scan speed Poor optic disc measurements Time Domain OCT susceptible to eye movements 768 pixels (A-scans) captured in 1.92 seconds is slower than eye movements Stabilizing the retina reveals true scan path (white circles) 1 1. Koozekanani, Boyer and Roberts. Tracking the Optic Nervehead in OCT Video Using Dual Eigenspaces and an Adaptive Vascular Distribution Model ; IEEE Transactions on Medical Imaging, Vol. 22, No. 12, 2003 Time Domain OCT artifacts can be common Spectral Domain OCT Time Domain OCT Stratus SPECTRALIS 1. Sadda, Wu, et al. Ophthalmology 2006;113:285-293 2. Ray, Stinnett, Jaffe. Am J Ophth 2005; 139:18-29 3. Bartsch, Gong, et al. Proc. of SPIE Vol. 5370; 2140-2151 Spectral Domain Comparison Spectral Domain: Many Options Typical SD OCT SD OCT w/tracking & Noise Reduction Michael Chaglasian, OD 4

Spectral Domain: Many Options Still Valuable: But Perhaps Limited Future (I am unaware of any timelines) Optical Coherence Tomography RS-3000 Advance NOT FDA Approved for US Sales GDx Stratus Spectral Domain: Why?? Image Management Systems Enhanced reproducibility and registration. Objective quantitative data that supports standardization of care at an expert level. Pinpoint correlations in ocular structure and function, matching areas of abnormal tissue with attendant vision problems. Progression Analysis Cirrus HD OCT: Optic Nerve Head Analysis This analysis: Automatically identifies the optic disc and cup boundaries. Is generated using the dense data in the Optic Disc 200x200 data cube and a proprietary ZEISS algorithm. Is designed to precisely measure the neuro retinal rim while accounting for tilted discs, disruptions to the RPE and other challenging pathology. 39 Michael Chaglasian, OD 5

Printout RNFL THICKNESS MAP shows the patterns and thickness of the nerve fiber layer within the full 6mm x 6mm area RNFL thickness and comparison to normative data is shown in circle, quadrants and clock hour display RNFL DEVIATION MAP, overlaid on the OCT fundus image, illustrates precisely where RNFL thickness deviates from the normal range. Data points that are not within normal limits are indicated in red and yellow. Quadrant and Sector MAPs in middle of page Signal Strength Here How to Read a Printout FIRST!: Signal Strength A KEY indicator of image quality Should be 7/10 or higher on Cirrus DO NOT interpret poor quality scan as red disease Well centered image No evidence of movement artifact Review Plots and Displays Thickness Map and Deviation Map Quadrant and Sector Plots TSNIT and Optic Nerve B Scan Glaucoma RNFL Thickness Analysis The RNFL thickness map shows the patterns and thickness of the nerve fiber layer within the 6mm x 6mm cube Yellow and Red = Good / Normal The RNFL deviation map is overlaid on the OCT fundus image to illustrate precisely where RNFL thickness deviates from a normal range Yellow and Red = Bad / Abnormal Glaucoma RNFL Thickness Analysis: TSNIT RNFL thickness is displayed in graphic format and compared to agematched normative data Michael Chaglasian, OD 6

Normative Data: Glaucoma Average RNFL Thickness RNFL Symmetry Rim Area Disc Area Average C/D Ratio Vertical C/D Ratio Cup Volume Distribution of Normals: Color coded indication of normative data comparison for RNFL and ONH. The thickest 5% fall in the white area. 90% of measurements fall in the green area. The thinnest 5% fall in the yellow area or below. The thinnest 1% of fall in the red area. Measurements in red are considered outside normal limits. ONH values will be shown in gray when the disc area does not match with normative data. Example Normative Data: Example Normative Data: Cirrus HD OCT SD-OCT - Heidelberg Engineering Spectralis Options SD-OCT Spectralis 70,000 scans per sec. 52 Michael Chaglasian, OD 7

Eye Tracking Optovue: RTVue Reference scan Cross section scan EYE TRACKING Eye Movement The reference image tracks eye movement, and the cross section is moved to match Optovue Family Diagnostic Testing for WGA Glaucoma 1. A method for detecting abnormality and also documenting optic nerve structure should be part of routine clinical management of glaucoma. 2. According to limited evidence available sensitivity and specificity of imaging instruments for detection of glaucoma are comparable to that of expert 3. Digital imaging is recommended as a clinical tool to enhance and facilitate the assessment of the optic disc and retinal nerve fiber layer in the management of glaucoma. 55 The Global Glaucoma Network Diagnostic Testing for Glaucoma WGA 4b. Automated analysis of change using appropriate assessment of variability is helpful for identifying change consistent with glaucoma. 5. Different imaging technologies may be complementary, and detect different abnormal features in the same patients. Note: At this time, evidence does not preferentially support any one of the above structural tests for diagnosing glaucoma. The Global Glaucoma Network What are practitioners' most common misunderstandings of imaging technology? The thought that these devices can diagnose glaucoma in the absence of corroborating clinical evidence is, in my opinion, the most common (and potentially dangerous) misunderstanding. The limited normative databases against which scans are compared can never cover the remarkably varied appearance and structure of the optic nerve we encounter in normal individuals. James Brandt, MD Michael Chaglasian, OD 8

Red Disease! Red Disease CASE AK 54 year old woman Recently moved from Poland VA = 20/40 and 20/50 14D myope Current Medications Dorzolamide TID Timolol BID Complaints of topical SE s with drops CASE AK Michael Chaglasian, OD 9

Glaucoma Madness Plethora of information Nothing Definitive in Early Stages Nothing Stable ONH IOP-C/D Ratio Pachymetry Gonio family history Ethnicity Stereo Photos Pallor Rim Area Asymmetry-Blood Flow Visual Fields FRUSTRATION Increasing Prevalence of Glaucoma Increasing Prevalence: African American IOVS, Special Issue 2012, Vol. 53, No. 5 IOVS, Special Issue 2012, Vol. 53, No. 5 Increasing Prevalence: Hispanic Can you have glaucoma in the macula? New Scan Patterns for Glaucoma Suspects IOVS, Special Issue 2012, Vol. 53, No. 5 70 Michael Chaglasian, OD 10

Zeiss: Ganglion Cell Analysis Measures thickness for the sum of the ganglion cell layer and inner plexiform layer (GCL + IPL layers) using data from the Macular 200 x 200 or 512 x 128 cube scan patterns. Anatomy: Ganglion Cell Layer and IPL Carl Zeiss Meditec, Inc Cirrus 6.0 Speaker Slide Set CIR.3992 Rev B 01/2012 Cirrus: Ganglion Cell Analysis The analysis contains: Data for both eyes (OU) Thickness Map shows thickness measurements of the GCL + IPL in the 6mm by 6mm cube and contains an elliptical annulus centered about the fovea. Deviation Maps shows a comparison of GCL + IPL thickness to normative data. Thickness table shows average and minimum thickness within the elliptical annulus. Ganglion Cell Analysis 74 Carl Zeiss Meditec, Inc Cirrus 6.0 Speaker Slide Set CIR.3992 Rev B 01/2012 The Ganglion Cell Complex (GCC) RTVue: RNFL and GCC Inner retinal layers provide complete Ganglion cell assessment: Nerve fiber layer (g cell axons) Ganglion cell layer (g-cell body) Inner plexiform layer (g-cell dendrites) Images courtesy of Dr. Ou Tan, USC Michael Chaglasian, OD 11

Disc Photos CASE EE IOP 21 24 mmhg CCT 545 Visual Fields Combined Report Michael Chaglasian, OD 12

Disc Photos CASE MZ IOP in high teens CCT= 560 Visual Fields CASE ML 47 yrs old GAT = ~ 20 21 OD and OS Asymmetric Cupping CCT= 525 OD OS Referred for Treatment Michael Chaglasian, OD 13

Baseline VFs #1 Baseline VFs #2 Photos 2 Years Later Detecting Structural Progression of Glaucoma A Key Component of Glaucoma Management Cirrus HD-OCT Guided Progression Analysis Image Progression Map Two baseline exams are required GPA Analysis SS = 10 Baseline Registration SS = 10 Baseline Baseline Registration SS = 8 Registration SS = 9 Third exam is compared to the two baseline exams Sub pixel map demonstrates change from baseline Yellow pixels denote change from both baseline exams Third and fourth exams are compared to both baselines. Change identified in three of the four comparisons is indicated by red pixels; yellow pixels denote change from both baselines Change refers to statistically significant change, defined as change that exceeds the known variability of a given pixel based on population studies Michael Chaglasian, OD 14

250 200 150 100 50 0 0 50 100 150 200 250 TSNIT How to Be Efficient and Effective with Cirrus HD-OCT GPA Analysis RNFLT (microns) TSNIT Progression Graph TSNIT values from each exam are shown Significant difference is colorized yellow or red Yellow denotes change from both baseline exams Red denotes change from 3 of 4 comparisons New Updates on Cirrus HD-OCT (Zeiss): Ganglion Cell Analysis Trend Analysis: Summary Parameter A Regression Line is drawn to determine rate of change for all the data that has been collected over time. Less variability with Structural/OCT testing as compared to Functional/ Visual Field testing. Ver 6.0 Updated Guided Progression Analysis (GPA ) Optic Nerve Head information now included Average Cup-to-Disc Ratio plotted on graph with rate of change information. Updated Guided Progression Analysis (GPA ) Page 1 Page 2 RNFL/ONH Summary includes item Average Cup-to- Disc Progression. Printout includes an optional second page with table of values, including Rim Area, Disc Area, Average & Vertical Cup-to-Disc Ratio and Cup Volume. Each cell of the table can be color coded if change is detected. Ver 6.0 Ver 6.0 98 Structure vs. Function Michael Chaglasian, OD 15